GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ReShape Lifesciences
ReShape Lifesciences produces medical devices to combat obesity. Its stock price reflects its battle for market share and the commercial success of its products, such as the gastric balloon. The stock is volatile and dependent on sales news.
Share prices of companies in the market segment - Therapeutic medical equipment
ReShape Lifesciences is a medical company offering a portfolio of products and services to combat obesity and metabolic diseases. We've classified it as a "Therapeutic Medical Device." The chart below shows how the market values companies in the bariatric medicine sector.
Broad Market Index - GURU.Markets
ReShape Lifesciences is a medical company offering a portfolio of products and services to combat obesity and metabolic diseases. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with ReShape's performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
RSLS - Daily change in the company's share price ReShape Lifesciences
ReShape Lifesciences Inc.'s daily share price fluctuations reflect the volatility of the obesity treatment sector. The metric demonstrates sensitivity to demand for its gastric balloons and other non-surgical weight loss treatments.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-related products and services, including gastric balloons. The weight-loss medical device sector is competitive and innovative. The chart below shows the volatility in this niche, allowing one to assess the performance of RSLS against its peers.
Daily change in the price of a broad market stock, index - GURU.Markets
ReShape Lifesciences produces medical devices for obesity, including gastric balloons. The stock price of this innovative medtech company reflects the demand for non-surgical weight loss methods. Its price movement reflects the contribution of innovative medicine to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ReShape Lifesciences
ReShape Lifesciences' year-over-year performance tells the story of its obesity-fighting portfolio. Its market cap change over the past 12 months reflects both sales of its gastric balloon and its efforts to compete in an era of new, highly effective weight-loss drugs, which presents an existential challenge.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
ReShape, as a company offering weight loss solutions, is a bet on the fight against obesity. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its products and compete with pharmaceutical giants in this vast market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ReShape Lifesciences, with its obesity-fighting products, reflects the demand for weight-loss solutions. Its performance, compared to the market, reflects the competition between medical devices and pharmaceuticals and the company's ability to effectively market its products to doctors and patients.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ReShape Lifesciences
ReShape is a medical company offering solutions to combat obesity. Its monthly performance is driven by sales of its gastric balloon and other products. Quarterly revenue reports and competition in the bariatric solutions market are key.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-related products and services, including an intragastric balloon and a telemedicine platform. The chart below shows the overall dynamics of the therapeutic equipment sector, reflecting the huge demand for weight loss solutions.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of companies producing medical weight-loss products are driven by consumer spending on health. The chart below shows the overall sentiment. Is ReShape Lifesciences following these trends, or is its innovative product creating its own demand?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ReShape Lifesciences
The weekly performance of ReShape, a company that produces devices to combat obesity, reflects this global epidemic. Its stock price is responding to demand for its gastric balloons and competition from new weight-loss drugs.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
ReShape Lifesciences offers obesity-fighting products, including gastric balloons. This chart compares its weekly performance with the medical device sector and helps us understand how it competes with new weight-loss medications and other surgical methods.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ReShape Lifesciences produces weight-loss devices. This business relies on consumer spending on health and beauty. The chart below shows how RSLS shares, as a cyclical company, react to overall market expectations for the economy.
Market capitalization of the company, segment and market as a whole
RSLS - Market capitalization of the company ReShape Lifesciences
ReShape's market capitalization chart tells the story of a company producing medical devices to combat obesity. Its decline reflects the fierce competition from new weight-loss drugs, which threaten the future of its products. Its dynamics reflect the market's assessment of its ability to adapt to the changing landscape.
RSLS - Share of the company's market capitalization ReShape Lifesciences within the market segment - Therapeutic medical equipment
ReShape Lifesciences offers products to combat obesity. The company's share of market capitalization in its medical device segment reflects its niche position. The chart below illustrates how the market evaluates its technologies and their competitiveness in the large and complex obesity treatment market.
Market capitalization of the market segment - Therapeutic medical equipment
ReShape Lifesciences offers solutions to combat obesity, including intragastric balloons and a gastric banding system. The chart below shows the market capitalization of the medical device sector. Its dynamics reflect the growing global problem of obesity and the search for effective treatments.
Market capitalization of all companies included in a broad market index - GURU.Markets
ReShape Lifesciences offers obesity-fighting products, such as gastric balloons. Its market cap reflects the global obesity epidemic and the search for effective treatments. Its performance on the overall chart reflects how medicine and technology are addressing one of the most challenging health issues.
Book value capitalization of the company, segment and market as a whole
RSLS - Book value capitalization of the company ReShape Lifesciences
ReShape Lifesciences' foundation is its capital and manufacturing capabilities for producing FDA-approved obesity-fighting systems, such as gastric balloons. This represents real, medical capital for non-surgical weight loss. How has this niche medical technology asset evolved? The chart below shows its dynamics.
RSLS - Share of the company's book capitalization ReShape Lifesciences within the market segment - Therapeutic medical equipment
ReShape Lifesciences manufactures and markets FDA-approved weight-loss devices such as gastric balloons. The chart shows the proportion of its manufacturing and R&D assets, reflecting the physical scale of its obesity treatment business.
Market segment balance sheet capitalization - Therapeutic medical equipment
ReShape, a manufacturer of weight-loss devices, is a moderately capital-intensive business. This requires ownership of R&D and control over production. The BCap_Seg chart for the medical equipment sector shows that innovation requires a material base.
Book value of all companies included in the broad market index - GURU.Markets
ReShape Lifesciences' assets are its FDA-approved obesity products, such as the gastric balloon and gastric banding system. Its balance sheet reflects its patents and manufacturing capabilities. The chart below shows the company's market share in bariatric solutions.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ReShape Lifesciences
ReShape Lifesciences offers obesity-fighting products, including gastric balloons. Its balance sheet consists of patents and product inventory. Its market capitalization is determined by the market's assessment of the effectiveness and demand for its solutions in the context of the global obesity epidemic.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-fighting products, including an FDA-approved intragastric balloon. Its market share in the non-surgical weight loss market and competition from new, effective treatments are shown in the graph.
Market to book capitalization ratio for the market as a whole
ReShape Lifesciences produces medical devices to combat obesity. The company's value is determined by its patents, technologies, and market share. This chart compares how investors value the medical device sector, which addresses global health issues, against overall market trends.
Debts of the company, segment and market as a whole
RSLS - Company debts ReShape Lifesciences
ReShape Lifesciences, a company that produces medical devices for the treatment of obesity, uses capital to commercialize its products and conduct clinical trials. This chart shows how the company finances its efforts to promote its technologies in the competitive bariatric market, which requires investments in marketing and physician training.
Market segment debts - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity treatment products, including gastric balloons. This chart illustrates how the medical device company manages its finances to market its products and conduct research in the highly competitive field of bariatric medicine.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ReShape Lifesciences
ReShape Lifesciences offers a portfolio of obesity treatment products, including gastric balloons. This chart shows how the company uses debt to market its products and conduct further research in the highly competitive field of bariatric medicine. It helps assess its financial sustainability.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-fighting products, including a gastric balloon and a gastric banding system. This is a competitive market. The chart shows the overall debt burden in the medical device sector, which helps assess how ReShape finances the marketing and sales of its products.
Debt to book value of all companies in the market
ReShape Lifesciences offers products to combat obesity, which requires investment in marketing, physician training, and regulatory approvals. This chart, showing the overall debt burden in the market, helps understand how a medical device company manages its debt to achieve growth and profitability in a competitive environment.
P/E of the company, segment and market as a whole
P/E - ReShape Lifesciences
ReShape Lifesciences offers a portfolio of products for the treatment of obesity and metabolic diseases, including a gastric balloon. This chart shows how the market is evaluating its weight loss solutions. The trend reflects competition from other obesity treatments, including new drugs.
P/E of the market segment - Therapeutic medical equipment
Weight loss devices produced by ReShape Lifesciences represent a large but complex market. This chart shows the average valuation for medical device companies. It helps understand how investors view ReShape and its obesity products, as well as its ability to compete with pharmaceuticals and other surgical options.
P/E of the market as a whole
ReShape Lifesciences is a medical company offering obesity treatment products. Its valuation hinges on the success of its products, such as its adjustable gastric band. General market sentiment, reflected in this chart, has little impact on its business, which is driven by the specifics of the bariatric medicine market and competition.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ReShape Lifesciences
This chart for ReShape Lifesciences, a company that produces medical devices for obesity treatment, shows market expectations for future sales. It reflects forecasts for growth in demand for non-surgical weight loss methods and the company's ability to commercialize its products, such as gastric balloons.
%20P%2FE%20ReShape%20Lifesciences&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ReShape-Lifesciences&v=1772588388047 "Chart of the company's future (projected) P/E ReShape Lifesciences")
Future (projected) P/E of the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of products for the treatment of obesity and metabolic diseases, including the adjustable Lap-Band gastric band and patient support services. The chart shows forecasts for the medical device sector. This helps assess how the market perceives demand for ReShape products as new, effective weight loss medications emerge.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772588388120 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
ReShape Lifesciences Inc. offers obesity treatment products, including gastric balloons. Demand for these procedures is growing, but competition is fierce. This trend in overall consumer sentiment influences people's willingness to pay for weight loss procedures, which are not always covered by insurance.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772588388297 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ReShape Lifesciences
ReShape Lifesciences offers a portfolio of obesity-fighting products, including gastric balloons and the Lap-Band system. The company's revenue depends on sales of its weight-loss devices. This chart shows how the company performs in the growing but competitive bariatric market.
Profit of companies in the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-fighting products, including the adjustable Lap-Band gastric band and telemedicine services. This sector profitability chart illustrates the seriousness of the global obesity problem. They provide patients and physicians with comprehensive weight loss and health improvement solutions.
Overall market profit
ReShape Lifesciences offers a portfolio of obesity-fighting products, including intragastric balloons and a gastric banding system. Demand for these solutions is growing due to the global obesity epidemic. Overall economic stability, reflected in this graph, impacts the ability of patients and insurers to cover these procedures.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ReShape Lifesciences
ReShape Lifesciences offers a portfolio of obesity-fighting products, including the adjustable Lap-Band gastric band and an integrated patient support platform. This chart reflects analysts' expectations for growing demand for weight loss solutions and the company's ability to compete in the bariatric market.
%20profit%20of%20the%20company%20ReShape%20Lifesciences&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ReShape-Lifesciences&v=1772588388487 "Graph of future (projected) profit of the company ReShape Lifesciences")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
ReShape Lifesciences is a medical device company offering a portfolio of products for the treatment of obesity and metabolic diseases, including a gastric balloon. Growth is driven by demand for less invasive weight loss methods. This chart for the medical device sector shows the overall growth expectations for the bariatric technology market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772588388510 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
ReShape Lifesciences offers obesity treatment products, including gastric balloons. Demand for these procedures varies based on income and insurance coverage. This dynamic, reflecting economic expectations, impacts people's ability to afford procedures often considered cosmetic.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772588388568 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ReShape Lifesciences
ReShape Lifesciences is a company that produces medical devices for the treatment of obesity and metabolic diseases, including gastric balloons. The chart below shows how investors estimate its revenue from product sales. It reflects the vast yet competitive obesity market and the potential of its less invasive solutions.
P/S market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-fighting products, including a gastric balloon and a gastric banding system. The company's revenue depends on sales of these medical devices. This chart, which displays the average valuation in the medical device sector, helps understand how investors value ReShape's solutions in the large and growing bariatric market.
P/S of the market as a whole
ReShape Lifesciences is a medical device company that offers solutions for obesity and metabolic diseases, including the Lap-Band adjustable gastric band. This chart, showing the average market revenue estimate, helps understand how investors value the company in the large but competitive obesity market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ReShape Lifesciences
ReShape Lifesciences is a medical device company that treats obesity. Its product portfolio includes the Lap-Band adjustable gastric band and other non-surgical solutions. This chart shows how investors estimate future demand for its products amid the global obesity epidemic and competition from new drugs.
%20P%2FS%20ReShape%20Lifesciences&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ReShape-Lifesciences&v=1772588388803 "The graph of the company's future (projected) P/S ReShape Lifesciences")
Future (projected) P/S of the market segment - Therapeutic medical equipment
ReShape Lifesciences Inc. is a medical device company offering a portfolio of products for the treatment of obesity and metabolic diseases, including the Lap-Band adjustable gastric band. This chart shows the average future sales estimate for the medical device sector. It helps understand how the market views ReShape's obesity-related products.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772588388900 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
ReShape Lifesciences offers a portfolio of obesity-fighting products, including a gastric balloon and a gastric banding system. This chart illustrates general market expectations. Demand for the company's products reflects the global obesity problem and the growing desire for effective, less invasive weight loss methods.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772588388971 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ReShape Lifesciences
This chart shows sales for ReShape Lifesciences, a company offering a portfolio of weight loss products, including the Lap-Band system and an intragastric balloon. Revenue is generated from sales of these medical devices. The trend reflects the demand for obesity solutions and competition in this field.
Sales of companies in the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of products for the treatment of obesity and metabolic diseases, including the Lap-Band adjustable gastric band. This chart illustrates the growth of the bariatric solutions market. The company's products are a vital part of the fight against the global obesity epidemic, and demand for them reflects overall trends in healthcare and wellness.
Overall market sales
ReShape Lifesciences offers obesity-fighting products, including gastric balloons. Demand for its products is driven by consumer spending on health and aesthetic medicine. This total revenue chart reflects people's ability to afford weight-loss procedures, which are not always covered by insurance.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ReShape Lifesciences
ReShape Lifesciences offers a portfolio of obesity-fighting products, including gastric balloons and a gastric banding system. Future revenue depends on demand for minimally invasive weight loss methods. The chart below shows the bariatric technology market forecast.
%20sales%20of%20the%20company%20ReShape%20Lifesciences&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ReShape-Lifesciences&v=1772588389228 "Schedule of future (projected) sales of the company ReShape Lifesciences")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-fighting products, including the Lap-Band adjustable gastric band and patient support services. This chart shows the forecast for the entire therapeutic device market, where obesity is one of the most serious and growing health problems globally.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772588389267 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
ReShape Lifesciences offers a portfolio of obesity-fighting products, including gastric balloons and a gastric banding system. Demand for their products is driven by consumer health spending. This chart, illustrating consumer confidence, helps assess people's willingness to pay for weight-loss procedures, which are often not covered by insurance.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772588389295 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ReShape Lifesciences
ReShape Lifesciences offers a portfolio of obesity-fighting products, including intragastric balloons and a gastric banding system. The company's profitability depends on successful sales of these medical devices and their acceptance by patients and physicians. This chart shows the financial performance of the company, which operates in the large but competitive bariatric market.
Market segment marginality - Therapeutic medical equipment
ReShape Lifesciences is a medical device company offering a portfolio of products for the treatment of obesity and metabolic diseases, including gastric balloons. Profitability depends on the decision-making of physicians and patients. This chart shows operating results in the competitive bariatric and metabolic solutions market.
Market marginality as a whole
ReShape Lifesciences is a medical company offering a portfolio of obesity-fighting products, including a gastric balloon and gastric banding system. This overall profitability profile is important to them, as many weight-loss procedures are not fully covered by insurance and require significant out-of-pocket expenses, which depend on the financial well-being of patients.
Employees in the company, segment and market as a whole
Number of employees in the company ReShape Lifesciences
ReShape Lifesciences develops and markets medical devices to combat obesity. Its team includes engineers and a key sales team working with physicians and clinics. This chart reflects its commercial efforts to promote its products in the bariatric market.
Share of the company's employees ReShape Lifesciences within the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of obesity-fighting products, including an FDA-approved gastric balloon system. This chart reflects the scale of its commercial operations. It shows the size of the team dedicated to promoting these minimally invasive solutions to physicians and patients as an alternative to surgery.
Number of employees in the market segment - Therapeutic medical equipment
ReShape Lifesciences Inc. is a medical device company offering a portfolio of products to treat obesity and metabolic diseases. This chart shows employment trends in the bariatric medicine sector. The growth in sales and clinical support positions reflects the growing problem of obesity and the demand for less invasive treatments than traditional surgery.
Number of employees in the market as a whole
ReShape Lifesciences offers obesity treatment products, including gastric balloons. Demand for these procedures is largely discretionary. This overall occupancy chart reflects the financial situation of potential patients. A stable income and good insurance coverage increase the likelihood that people will invest in such procedures.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ReShape Lifesciences (RSLS)
ReShape Lifesciences is a medical company offering solutions to combat obesity, including a gastric balloon and a band (Lap-Band). It is a medical device company. The chart shows the market value of their product portfolio. The cost per employee reflects the balance between R&D, manufacturing, and the effectiveness of the sales team working with bariatric surgeons.
%20of%20the%20company%20ReShape%20Lifesciences%20(RSLS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ReShape-Lifesciences-RSLS&v=1772588389556 "Chart of market capitalization per employee (in thousands of dollars) of the company ReShape Lifesciences (RSLS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of weight loss products, including gastric balloons and a gastric banding system. It is a medical device company. This chart shows how the market views its patented products and their potential in the large obesity market.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772588389609 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
ReShape Lifesciences offers a portfolio of obesity-fighting products, including gastric balloons. The chart below shows their valuation in the MedTech sector. It reflects how the market perceives their products' ability to offer patients less invasive and more affordable options compared to bariatric surgery.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772588389632 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ReShape Lifesciences (RSLS)
ReShape Lifesciences is a medical company specializing in non-surgical weight loss solutions. Their flagship product is an FDA-approved gastric balloon that helps patients feel full. This graph shows how successfully their small sales and marketing team can sell this niche procedure.
%20Chart%20ReShape%20Lifesciences%20(RSLS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ReShape-Lifesciences-RSLS&v=1772588389680 "Company Profit Per Employee (in thousands of dollars) Chart ReShape Lifesciences (RSLS)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
ReShape Lifesciences offers a portfolio of weight loss products, including a gastric balloon and the Lap-Band gastric banding system. This metric reflects the company's success in marketing its medical devices in the highly competitive bariatric field.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772588389814 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
ReShape Lifesciences (RSLS) is a medical technology company producing devices for obesity treatment (such as a gastric balloon). This includes R&D and manufacturing. This graph likely represents the loss per employee, reflecting the difficulty of commercializing their product (direct-to-consumer sales, competition).
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772588389919 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ReShape Lifesciences (RSLS)
ReShape Lifesciences offers a portfolio of obesity treatment products, including gastric balloons and a gastric banding system. This chart demonstrates the commercial success of its medical devices. The increase in revenue per employee reflects the high demand for its weight loss solutions and the effectiveness of its sales team in reaching physicians.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ReShape-Lifesciences-RSLS&v=1772588390021 "Sales chart per company employee ReShape Lifesciences (RSLS)")
Sales per employee in the market segment - Therapeutic medical equipment
ReShape Lifesciences (RSLS) offers solutions to combat obesity. Their portfolio includes the renowned Lap-Band gastric banding system and the swallowable gastric balloon. This chart shows the revenue generated by each employee (engineer, sales specialist) from sales of these medical devices.
Sales per employee for the market as a whole
ReShape Lifesciences (RSLS) offers integrated obesity treatment solutions, including the FDA-approved Lap-Band intragastric balloon and a telemedicine platform. This chart shows how successfully the company generates revenue from sales of its medical devices and services, which requires both manufacturing and medical/service personnel.
Short shares by company, segment and market as a whole
Shares shorted by company ReShape Lifesciences (RSLS)
ReShape Lifesciences sells weight-loss devices such as gastric balloons. The bearish sentiment shown in this chart reflects an existential threat to its business. Investors are betting that new injectables (Ozempic, Wegovy) will render its invasive devices completely obsolete.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ReShape-Lifesciences-RSLS&v=1772588390252 "Short Shares Chart for the Company ReShape Lifesciences (RSLS)")
Shares shorted by market segment - Therapeutic medical equipment
This reflects investor sentiment in the weight-loss equipment sector. ReShape Lifesciences offers gastric balloons. If investors are short this segment, they could be betting on the growing popularity of GLP-1 drugs (like Ozempic), which reduce the need for surgical and device-based obesity treatments.
Shares shorted by the overall market
ReShape Lifesciences sells weight-loss equipment (a gastric balloon). It's considered "aesthetic" medicine, an optional expense. This chart reflects the overall market pessimism. Investors fear that during a recession, consumers will abandon expensive "lifestyle" procedures not covered by insurance.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ReShape Lifesciences (RSLS)
ReShape Lifesciences (RSLS) offers solutions to combat obesity, including the FDA-approved Lap-Band gastric balloon. This indicator tracks how investors view the commercial launch of their products, indicating "overbought" (above 70) on positive sales reports or "oversold" (below 30) on competitive concerns.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ReShape-Lifesciences-RSLS&v=1772588390440 "RSI 14 indicator chart for the company's stock ReShape Lifesciences (RSLS)")
RSI 14 Market Segment - Therapeutic medical equipment
ReShape Lifesciences (RSLS) specializes in obesity management. They offer a portfolio of weight loss solutions, including the Lap-Band gastric banding system and Obalon intragastric balloons. This chart measures the overall momentum in the medical device sector and helps assess whether the entire segment is overheated.
RSI 14 for the overall market
ReShape (RSLS) offers weight loss solutions—a "wellness" service. This chart is an indicator of spending on "luxury." In moments of euphoria and the "wealth effect," people are eager to spend on "anti-aging" products. In times of panic and recession, these "non-essential" medical procedures are the first to be postponed.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RSLS (ReShape Lifesciences)
ReShape (RSLS) is a medical device company specializing in weight loss devices, including the Lap-Band system (gastric banding). This chart shows the average price target. It reflects analysts' opinions on whether the company's surgical business can survive the rise of GLP-1 weight loss drugs (Ozempic).
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RSLS-ReShape-Lifesciences&v=1772588390532 "A chart showing analyst consensus forecasts for the expected stock price. RSLS (ReShape Lifesciences)")
The difference between the consensus estimate and the actual stock price RSLS (ReShape Lifesciences)
ReShape (RSLS) is "fighting obesity." The company is commercializing the FDA-approved "gastric balloon" (Lap-Band), a non-surgical weight loss method. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe they can compete with the "tsunami" of new drugs (GLP-1).
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RSLS-ReShape-Lifesciences&v=1772588390593 "A chart showing the difference between the consensus forecast and the actual stock price. RSLS (ReShape Lifesciences)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
ReShape is a medtech company fighting obesity. It offers a "comprehensive" solution, from a gastric balloon (Lap-Band) to telemedicine. This chart reflects analysts' overall expectations for the *entire* medical device sector. It shows whether experts believe in "non-drug" weight loss methods.
Analysts' consensus forecast for the overall market share price
ReShape Lifesciences (RSLS) – "non-surgical" weight loss. They sell a "gastric balloon" (Lap-Band), which is implanted to treat obesity. They're betting on the obesity "epidemic." This chart shows the general sentiment among experts. It reflects how confident analysts are in the stability of spending on "elective" medical procedures.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ReShape Lifesciences
ReShape is a weight-loss MedTech. Their specialty is non-invasive (no surgery) weight-loss devices, ranging from a gastric balloon (which you swallow) to smart scales (SaaS). (Duplicate of HIND). This chart is a summary of their D2C model. It reflects their (unprofitable) sales growth and their uphill battle to break into the hypercompetitive weight-loss market.
AKIMA Market Segment Index - Therapeutic medical equipment
ReShape Lifesciences (RSLS) is a therapeutic weight-loss device company. Their flagship product is the Lap-Band, an approved gastric banding system for obesity. This chart compares their composite index to the sector, showing how their weight-loss technology compares to the competition.
The AKIM Index for the overall market
ReShape Lifesciences is a medtech company offering weight loss products (Lap-Band). It is merging with Vyome Therapeutics. This chart, which reflects the market average, is just a backdrop. It helps assess how this player in the obesity sector stacks up against overall macroeconomic trends.
